Champions Oncology, Inc.CSBRNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-1.3x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -28.49% |
| 2024 | -17.33% |
| 2023 | 23.16% |
| 2022 | 30.27% |
| 2021 | 22.95% |
| 2020 | 21.99% |
| 2019 | 9.02% |
| 2018 | 2.52% |
| 2017 | 2.36% |
| 2016 | -13.44% |